Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States

Carolina Iglesias-Lopez; Antonia Agustí; Mercè Obach; Antonio Vallano

doi:10.3389/fphar.2020.00766

Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States

Front Pharmacol. 2020 May 25:11:766. doi: 10.3389/fphar.2020.00766. eCollection 2020.

Authors

Carolina Iglesias-Lopez¹, Antonia Agustí^{1

2}, Mercè Obach³, Antonio Vallano^{3

4}

Affiliations

¹ Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.
² Clinical Pharmacology Service, Vall d'Hebron University Hospital, Barcelona, Spain.
³ Medicines Department, Catalan Healthcare Service, Barcelona, Spain.
⁴ Pathology and Experimental Therapeutics Department, University of Barcelona, Barcelona, Spain.

Abstract

[This corrects the article DOI: 10.3389/fphar.2019.00921.].

Keywords: Europe; United States Food and Drug Administration; biological products; biological therapy; cell- and tissue-based therapy; genetic therapy; legislation and jurisprudence; tissue engineering.

Publication types

Published Erratum